StockClub
ETONEton Pharmaceuticals, Inc.$ --
Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc.

ETON

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
24M USD
YoY +40.4%
Operating Income
2M USD
YoY +613.6%
Net Income
2M USD
YoY +198.9%
EPS
0.06$
YoY +202.6%

Revenue

$24.3M
FY2024 Q2$17M
$17M
Q2
FY2024 Q3$27.4M
$27.4M
Q3
FY2024 Q4$39M
$39M
Q4
FY2025 Q1$17.3M
$17.3M
Q1
FY2025 Q2$36.2M
$36.2M
Q2
FY2025 Q3$58.7M
$58.7M
Q3
FY2025 Q4$80M
$80M
Q4
FY2026 Q1$24.3M
$24.3M
Q1
Actual
+$7M (+40.4%)

Net Income

$1.6M
FY2024 Q2$-3.9M
$-3.9M
Q2
FY2024 Q3$-3.2M
$-3.2M
Q3
FY2024 Q4$-3.8M
$-3.8M
Q4
FY2025 Q1$-1.6M
$-1.6M
Q1
FY2025 Q2$-4.2M
$-4.2M
Q2
FY2025 Q3$-6.1M
$-6.1M
Q3
FY2025 Q4$-4.6M
$-4.6M
Q4
FY2026 Q1$1.6M
$1.6M
Q1
Actual
+$3.1M (+198.9%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$39,000
Est:$1.2M
FY2020MISS
$39,000
FY2021MISS
Actual:$21.8M
Est:$23.3M
FY2021MISS
$21.8M
FY2022MISS
Actual:$21.3M
Est:$21.8M
FY2022MISS
$21.3M
FY2023BEAT
Actual:$31.6M
Est:$31.4M
FY2023BEAT
$31.6M
FY2024BEAT
Actual:$39M
Est:$37.9M
FY2024BEAT
$39M
FY2025BEAT
Actual:$80M
Est:$79.3M
FY2025BEAT
$80M

Analyst Estimates